{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:31:53Z","timestamp":1785259913597,"version":"3.55.0"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.18632\/oncotarget.28742","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:46:46Z","timestamp":1750171606000},"page":"495-507","source":"Crossref","is-referenced-by-count":5,"title":["Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience"],"prefix":"10.18632","volume":"16","author":[{"given":"Fei","family":"Fei","sequence":"first","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milhan","family":"Telatar","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Tomasian","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Danilova","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Arias-Stella","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Pillai","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Soma","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastou","family":"Tizro","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Afkhami","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Siebert","year":"2017"},{"key":"2","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.3390\/cancers13235888","article-title":"Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm","volume":"1","author":"Khoury","year":"2021","journal-title":"Cancers (Basel)"},{"key":"3","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Petrella","year":"2019","journal-title":"Blood Adv"},{"key":"4","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","article-title":"Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients","volume":"4","author":"Petrella","year":"2020","journal-title":"Blood Adv"},{"key":"5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2019001144","article-title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","volume":"13","author":"Rampal","year":"2019","journal-title":"Blood"},{"key":"6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm","volume":"4","author":"Loghavi","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41375-018-0154-5","article-title":"Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response","volume":"3","author":"Yamazaki","year":"2018","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"9","author":"Jaffe","year":"2010","journal-title":"Haematologica"},{"key":"9","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.modpat.2023.100253","article-title":"Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm","volume":"3","author":"Takeuchi","year":"2023","journal-title":"Mod Pathol"},{"key":"10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"9","author":"Todisco","year":"2013","journal-title":"Haematologica"},{"key":"11","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm","volume":"38","author":"Brooks","year":"2019","journal-title":"N Engl J Med"},{"key":"12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"12","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41409-021-01478-5","article-title":"Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)","volume":"5","author":"Ahmed","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"14","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1182\/bloodadvances.2020002415","article-title":"Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia","volume":"4","author":"Villasboas","year":"2020","journal-title":"Blood Adv"},{"key":"15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia","volume":"13","author":"Derkach","year":"2021","journal-title":"Blood"},{"key":"16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"2","author":"Frizzera","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1600-0560.2011.01777.x","article-title":"Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"3","author":"Petrella","year":"2011","journal-title":"J Cutan Pathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/PAS.0b013e31825dd4de","article-title":"Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases","volume":"3","author":"Samaleire","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"2","author":"Larrayoz","year":"2014","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/bloodadvances.2020003359","article-title":"Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis","volume":"5","author":"Petrella","year":"2021","journal-title":"Blood Adv"},{"key":"21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3324\/haematol.2018.202093","article-title":"Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target","volume":"10","author":"Sabattini","year":"2019","journal-title":"Haematologica"},{"key":"22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-20-1513","article-title":"Sex-BiasedMutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis","volume":"1","author":"Angelot-Delettre","year":"2022","journal-title":"Cancer Discov"},{"key":"23","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3324\/haematol.2020.253740","article-title":"Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape","volume":"10","author":"Bouyer","year":"2021","journal-title":"Haematologica"},{"key":"24","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.3390\/cancers14174132","article-title":"Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells","volume":"1","author":"Lefebvre","year":"2022","journal-title":"Cancers (Basel)"},{"key":"25","doi-asserted-by":"publisher","first-page":"e32904","DOI":"10.1097\/MD.0000000000032904","article-title":"Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review","volume":"10","author":"Deng","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.leukres.2018.09.006","article-title":"Genomic aberrations involving 12p\/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events","volume":"7","author":"Khoury","year":"2018","journal-title":"Leuk Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41375-023-01968-z","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies","volume":"3","author":"Ragoonanan","year":"2023","journal-title":"Leukemia"},{"key":"28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.5858\/arpa.2021-0612-RA","article-title":"An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases","volume":"14","author":"George","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/leu.2017.101","article-title":"Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm","volume":"3","author":"Sekiya","year":"2017","journal-title":"Leukemia"},{"key":"30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41408-019-0262-0","article-title":"Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)","volume":"9","author":"Pemmaraju","year":"2019","journal-title":"Blood Cancer J"},{"key":"31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","article-title":"Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients","volume":"3","author":"Wang","year":"2022","journal-title":"Leukemia"},{"key":"32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1080\/10428194.2021.1924372","article-title":"Comprehensive analysis of the genetic landscape of 21 cases with blastic plasmacytoid dendritic cell neoplasm by whole genome and whole transcriptome sequencing","volume":"6","author":"Stengel","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1182\/blood-2019-132185","article-title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Eraera","author":"Yin","year":"2019","journal-title":"Blood"},{"key":"34","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1182\/bloodadvances.2022007879","article-title":"TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm","volume":"7","author":"Pemmaraju","year":"2023","journal-title":"Blood Adv"},{"key":"35","doi-asserted-by":"publisher","first-page":"20406207241251602","DOI":"10.1177\/20406207241251602","article-title":"A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients","volume":"1","author":"Zhang","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/ejh.13959","article-title":"Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database","volume":"11","author":"Niu","year":"2023","journal-title":"Eur J Haematol"},{"key":"37","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/leu.2009.144","article-title":"Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia","volume":"2","author":"Pscherer","year":"2009","journal-title":"Leukemia"},{"key":"38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41422-020-0362-1","article-title":"A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I\/MDA5 for degradation during viral infection","volume":"3","author":"Zeng","year":"2021","journal-title":"Cell Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bjh.14146","article-title":"Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches","volume":"17","author":"Pulsoni","year":"2016","journal-title":"Br J Haematol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:46:47Z","timestamp":1750171607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,6,17]]}},"alternative-id":["28742"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28742","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}